Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) makes a critical contribution to the initiation and progression of pancreatic cancer via affecting diverse cellular events and G12D is one of notable missense mutations, constitutively activating KRAS in cancer cells [129]. This evidence concerns the gene KRAS and familial pancreatic carcinoma.